Max Brosa
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization
Papers in
- Epidemiology 13
- Hepatitis B Virus Studies 4
- Chronic Disease Management Strategies 3
- Pneumonia and Respiratory Infections 3
-
- Atrial Fibrillation Management and Outcomes 4
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- Carlos Crespo (17 shared papers)Maria Buti Ferret (5 shared papers)Rafael Esteban (4 shared papers)Miguel Ángel Casado (3 shared papers)Marc Miravitlles (5 shared papers)Alfonso Lopez-Alba (2 shared papers)Bernat Soria (2 shared papers)Xavier Costa Badia (6 shared papers)
In The Last Decade
Max Brosa
75 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 98
- Hepatology 131
- Immunology and Allergy 72
- Otorhinolaryngology 39
- Geriatrics and Gerontology 31
- Physiology 225
Countries citing papers authored by Max Brosa
This map shows the geographic impact of Max Brosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Brosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Brosa more than expected).
Fields of papers citing papers by Max Brosa
This network shows the impact of papers produced by Max Brosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Brosa. The network helps show where Max Brosa may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Brosa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 95 | |
| 2 | 2005 | 91 | |
| 3 | 2016 | 80 | |
| 4 | 2013 | 71 | |
| 5 | 2009 | 69 | |
| 6 | 2010 | 60 | |
| 7 | 2015 | 48 | |
| 8 | 2011 | 45 | |
| 9 | The burden of hospital malnutrition in Spain: methods and development of the PREDyCES® study. | 2011 | 44 |
| 10 | 2008 | 44 | |
| 11 | 2005 | 43 | |
| 12 | 2013 | 37 | |
| 13 | 2011 | 32 | |
| 14 | 1994 | 25 | |
| 15 | 2008 | 25 | |
| 16 | 2010 | 23 | |
| 17 | 2009 | 23 | |
| 18 | 2016 | 21 | |
| 19 | 2008 | 19 | |
| 20 | 2017 | 18 |
About Max Brosa
Max Brosa is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Rheumatology and Economics and Econometrics, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Atrial Fibrillation Management and Outcomes (4 papers), Hepatitis B Virus Studies (4 papers), Chronic Disease Management Strategies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pneumonia and Respiratory Infections (3 papers), Asthma and respiratory diseases (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Hepatology (131 citations), Immunology and Allergy (72 citations), Otorhinolaryngology (39 citations), Geriatrics and Gerontology (31 citations) and Physiology (225 citations). Max Brosa has collaborated with scholars based in Spain, France and Germany. Frequent co-authors include Carlos Crespo, Maria Buti Ferret, Rafael Esteban, Miguel Ángel Casado, Marc Miravitlles, Alfonso Lopez-Alba, Bernat Soria, Xavier Costa Badia, Julia Álvarez Hernández and Roberto Gasparini. Their work appears in journals such as Value in Health, PharmacoEconomics, Journal of Hepatology, BMC Pulmonary Medicine and Journal of Medical Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.